IL6 and metabolic syndrome: Serums levels of inflammatory (hs-CRP, IL-6, MPO), thrombogenic (PAI-1, D-dimer), and novel atherosclerotic (ESAM, LTBR) biomarkers were higher in individuals with MetS compared to individuals without MetS.